https://data.archives-ouvertes.fr/author/800408

https://data.archives-ouvertes.fr/author/800408

http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.can
http://xmlns.com/foaf/0.1/topic_interest Safety
http://xmlns.com/foaf/0.1/topic_interest SARS-CoV-2 antibodies
http://xmlns.com/foaf/0.1/topic_interest Biomarker
http://xmlns.com/foaf/0.1/topic_interest Cancer patients
http://xmlns.com/foaf/0.1/topic_interest SARS-CoV-2 infection
http://xmlns.com/foaf/0.1/topic_interest Polyomavirus
http://www.w3.org/2002/07/owl#sameAs 0000-0002-9902-5990
http://xmlns.com/foaf/0.1/firstName Charlée
http://xmlns.com/foaf/0.1/topic_interest Avelumab
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.mhep.derm
http://xmlns.com/foaf/0.1/topic_interest Exosomes
http://xmlns.com/foaf/0.1/topic_interest RB1 immunohistochemistry
http://xmlns.com/foaf/0.1/topic_interest Psoriasis
http://xmlns.com/foaf/0.1/name Charlée Nardin
http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://xmlns.com/foaf/0.1/Person
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.mp.vir
http://xmlns.com/foaf/0.1/topic_interest Anti-PD L1
http://xmlns.com/foaf/0.1/topic_interest Immunotherapy
http://xmlns.com/foaf/0.1/familyName Nardin
http://xmlns.com/foaf/0.1/topic_interest Immune T cell response
http://xmlns.com/foaf/0.1/topic_interest Biologics
http://xmlns.com/foaf/0.1/topic_interest Drug survival
http://xmlns.com/foaf/0.1/topic_interest PD-L1
http://xmlns.com/foaf/0.1/topic_interest SOX2
http://xmlns.com/foaf/0.1/topic_interest Merkel cell carcinoma
https://aurehal.archives-ouvertes.fr/author/800408

Télécharger au format  
RDF/XML Turtle N3 Json